Sol-Gel Technologies Announces Pricing of Oversubscribed Underwritten Offering for Dermatology Company.

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company focused on developing branded and generic topical drug products for skin diseases. The company uses its proprietary silica-based microencapsulation technology platform to enhance drug tolerability and stability while maintaining efficacy. The platform entraps active ingredients in an inert, inorganic silica shell, creating a barrier between the drug and the skin.